Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
Tingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 103
Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with Escherichia coli
Shuai Zhao, Wanting Zeng, Fang Yu, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 111-111
Open Access | Times Cited: 2
Recent advances in management of COVID-19: A review
Soraya Mouffak, Qamar Shubbar, Ekram Saleh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112107-112107
Open Access | Times Cited: 76
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Research progress and applications of nanobody in human infectious diseases
Yaxian Mei, Yuanzhi Chen, Jwala Sivaccumar, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 46
Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
Justin D. Walter, Melanie Scherer, Cedric A. J. Hutter, et al.
EMBO Reports (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 40
Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
Honghui Liu, Lili Wu, Bo Liu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100918-100918
Open Access | Times Cited: 35
L‐Glycosidase‐Cleavable Natural Glycans Facilitate the Chemical Synthesis of Correctly Folded Disulfide‐Bonded D‐Proteins
Weiwei Shi, Tongyue Wang, Ziyi Yang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 9
Closed Access | Times Cited: 13
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Genetically enabling phosphorus fluoride exchange click chemistry in proteins
Li Cao, Bingchen Yu, Shanshan Li, et al.
Chem (2024) Vol. 10, Iss. 6, pp. 1868-1884
Open Access | Times Cited: 8
Novel Nanobody Drug Conjugate as a Prophylactic or Therapeutic against SARS-CoV-2 infection in mice
Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151480-151480
Closed Access | Times Cited: 1
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies
Sarah A. Robinson, Matthew I. J. Raybould, Constantin Schneider, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 12, pp. e1009675-e1009675
Open Access | Times Cited: 42
Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
Bingchen Yu, Shanshan Li, Takako Tabata, et al.
Chem (2022) Vol. 8, Iss. 10, pp. 2766-2783
Open Access | Times Cited: 35
Structural Insights into the Design of Synthetic Nanobody Libraries
Mario S. Valdés‐Tresanco, Andrea Molina-Zapata, A. González, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2198-2198
Open Access | Times Cited: 32
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
Dhaneshree Bestinee Naidoo, Anil A. Chuturgoon
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 2, pp. 193-226
Open Access | Times Cited: 20
NbThermo: a new thermostability database for nanobodies
Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, Esteban Molina-Abad, et al.
Database (2023) Vol. 2023
Open Access | Times Cited: 18
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy
Yufei Xiang, Jialu Xu, Briana L. McGovern, et al.
Cell (2024)
Closed Access | Times Cited: 6
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma, Xinghai Zhang, Peiyi Zheng, et al.
Cell Research (2022) Vol. 32, Iss. 9, pp. 831-842
Open Access | Times Cited: 26
Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review
Hamid Aria, Fatemeh Mahmoodi, Hooria Seyedhosseini Ghaheh, et al.
Analytical Biochemistry (2022) Vol. 640, pp. 114546-114546
Open Access | Times Cited: 25
Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes
Halina Mikolajek, Miriam Weckener, Z. Faidon Brotzakis, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 25
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models
Martín A. Rossotti, Henk van Faassen, Anh Tran, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 25
The proximity-enabled sulfur fluoride exchange reaction in the protein context
Bingchen Yu, Li Cao, Shanshan Li, et al.
Chemical Science (2023) Vol. 14, Iss. 29, pp. 7913-7921
Open Access | Times Cited: 13
Nanobody engineering for SARS-CoV-2 neutralization and detection
Liina Hannula, Suvi Kuivanen, Jonathan Lasham, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 5
A Class of Shark‐Derived Single‐Domain Antibodies can Broadly Neutralize SARS‐Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape
Bo Feng, Zhilong Chen, Jing Sun, et al.
Small Methods (2022) Vol. 6, Iss. 7
Open Access | Times Cited: 19
Single Domain Antibody application in bacterial infection diagnosis and neutralization
Qian Qin, Hao Liu, Wenbo He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top